OmniAb SPAC Presentation Deck

OMNIAB'S HISTORICAL GROWTH WITHIN LIGAND PROGRESSION AND PERFORMANCE IN PROGRAMS BY STAGE OF DEVELOPMENT 2016 at Acquisition(¹) Preclinical: 1 21 (1) Estimated at the time of acquisition. Discovery: 20 Phase 2: 2 Phase 1: 18 Preclinical: 10. As of 12/31/21 Phase 3: 2 Registration: 1 252 -Approved: 2 Discovery: 217 Substantial progress in all phases, increase in discovery programs expected to rapidly feed growth in new clinical programs and future approvals 13 OmniAb

View entire presentation